Bristol-Myers Squibb

7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Bristol-Myers Squibb
Dapagliflozin
BioSante
Bio-T-Gel
Regeneron
Eylea
Transcept
Intermezzo
Incyte
ruxolitinib
Antares
Anturol
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bloomberg
Fri, 10/14/11 - 11:23 am
UK
Yervoy
Bristol-Myers Squibb
NICE
skin cancer
Positive Data on Forest Candidate
Yahoo/Zacks.com
Thu, 10/13/11 - 10:52 am
Forest Labs
antipsychotics
Bristol-Myers Squibb
Eli Lilly
cariprazine
FDA Warns Bristol Myers Leukemia Drug Could Cause Hypertension
FOX Business
Tue, 10/11/11 - 10:47 am
FDA
warnings
Bristol-Myers Squibb
leukemia
Sprycel
Checking the Quality of Perrigo's Growth
Motley Fool
Tue, 10/11/11 - 10:46 am
Perrigo Company
Abbott Laboratories
Dr Reddy's
Bristol-Myers Squibb
Agony From Lipitor's Expiration Won't Be Exclusive To Pfizer
Seeking Alpha
Mon, 10/10/11 - 06:37 pm
Pfizer
generics
Lipitor
patents
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Merck
Large-Cap Global Pharma Stocks May Provide Appreciation and Income
Seeking Alpha
Sat, 10/8/11 - 11:53 am
AstraZeneca
Merck
Bristol-Myers Squibb
GSK
Eli Lilly
Pfizer
Sanofi
Seeking Diversification Through Drug Company Dividend Stocks
Seeking Alpha
Thu, 10/6/11 - 12:00 pm
dividends
JNJ
Pfizer
Novartis
GSK
Merck
Sanofi
Abbott Laboratories
AstraZeneca
Amgen
Eli Lilly
Bristol-Myers Squibb
FDA to Respond to Bristol-Myers Drug
Yahoo/Zacks.com
Wed, 10/5/11 - 09:58 am
FDA
Bristol-Myers Squibb
Dapagliflozin
diabetes
AstraZeneca
Bristol-Myers Plans to Continue Growing Company, Chief Says
Bloomberg
Tue, 10/4/11 - 12:16 pm
Bristol-Myers Squibb
Pharma CEOs
Lamberto Andreotti
Dapagliflozin And Libigel Lead 4 October Healthcare Catalysts
Seeking Alpha
Tue, 10/4/11 - 11:23 am
LibiGel
Dapagliflozin
Antares
AstraZeneca
BioSante
Bristol-Myers Squibb
Teva Pharmaceuticals
Pacira
Biotech Calendar: Key Dates for October
TheStreet.com
Mon, 10/3/11 - 11:13 am
biotech
flurosorafenib
ONYX Pharmaceuticals
Bayer
Rigel
Teva Pharmaceuticals
Biogen Idec
BG-12
Heplisav
Amgen
Dynavax
Pacira
Bristol-Myers Squibb
Dapagliflozin
EXPAREL
cabozantinib
Exelixis
Biogen, Teva, Other Drug Makers Face Stock Catalysts in October
Minyanville
Sat, 10/1/11 - 01:59 pm
Biogen
Teva Pharmaceuticals
Novartis
Bristol-Myers Squibb
AstraZeneca
Alexion
Are HIV Drugmakers Doomed?
Motley Fool
Fri, 09/30/11 - 09:25 am
HIV
Pfizer
Merck
JNJ
Bristol-Myers Squibb
Sangamo BioSciences
Gilead
Abbott Laboratories
Bristol-Myers Squibb Zeroes In On A Blockbuster Cancer Drug
Seeking Alpha
Tue, 09/27/11 - 07:31 pm
Bristol-Myers Squibb
Orencia
MDX-1106
BMS-936558
Ono Pharmaceutical
9 Big Pharmas With The Least Side Effects
Seeking Alpha
Mon, 09/26/11 - 10:57 am
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Bristol-Myers Signs Deal
Yahoo/Zacks
Sat, 09/24/11 - 01:11 pm
Bristol-Myers Squibb
Ambrx
Fibroblast Growth Factor 21
FGF-21
Relaxin
diabetes
Healthcare: 8 Safe Bets For Dividends And Great Returns
Seeking Alpha
Sat, 09/24/11 - 12:52 pm
Abbot
Merck
Eli Lilly
JNJ
Bristol-Myers Squibb
Novartis
Pfizer
AstraZeneca
Bristol CEO says "pure pharma" strategy paying off
Reuters
Fri, 09/23/11 - 08:58 am
Bristol-Myers Squibb
Pharma CEOs
Lamberto Andreotti
Bristol pays $24M for early-stage biotech drugs
Yahoo/AP
Thu, 09/22/11 - 05:32 pm
Bristol-Myers Squibb
Ambrx
Relaxin
fibroblast activation protein

Pages